OR WAIT null SECS
Dosage Forms: Roundtable on Oral Solid Dosage Trends
Pharmaceutical packaging must advance to adapt to new, complex modalities
From Theory to Reality: Automating Process Development
The Importance of Appropriate Supplier Oversight
June 10, 2024
The new meeting program will create a dialogue around AI and be administered through CDER’s Emerging Drug Safety Technology Program.
USP and FDA publish reports detailing drug shortage numbers and challenges through 2023.
June 09, 2024
Artificial intelligence and machine learning can help overcome poor solubility and bioavailability.
June 08, 2024
The biopharma industry is looking at continuous chromatography for sensitive molecules.
The final drug product relies on the quality and reliability of the raw materials used in its production.
June 07, 2024
Lonza’s Joe Garrity and Jerry Jiang discuss the importance of not only automating CGT manufacturing, but also standardizing across processes.
Lonza’s Joe Garrity and Jerry Jiang discuss the latest trends and challenges in commercializing new CGTs.
In this episode of Drug Digest, industry experts discuss the current outsourcing landscape in the post-COVID world and the changes the pandemic has enforced in the demand for outsourced bioprocessing services.
June 06, 2024
Lars Petersen, CEO, FUJIFILM Diosynth Biotechnologies discusses the company’s strategic goals and meeting market demand for mammalian cell culture capacity.
Biosimilar analytical assessments focus on demonstrating biosimilarity and interchangeability with the reference biologic.